Corporate Banner
Satellite Banner
Technology Networks Header
Friday, April 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Cotton Rat RSV Model Launched by Noble Life Sciences and IBT Bioservices
Friday, January 31, 2014
Cotton rat model for preclinical studies of respiratory syncytial virus therapies and vaccines.

New Catalytic Converter Could Cut Fuel Consumption and Car Manufacturing Costs
Friday, January 31, 2014
New design of the device increases fuel efficiency.

MIP Technologies Presents New Range of RENSA™ Industrial Resins
Monday, January 27, 2014
New range of polymeric separation resins for industrial use.

Seward Stomacher® used for hygiene monitoring and biosecurity
Monday, January 27, 2014
Sponge swab and Stomacher technique proved to be highly effective sampling combination for assessing large surface areas

Malvern Instruments’ 2014 Webinar Program Gets Underway with Light Scattering
Tuesday, January 21, 2014
Malvern’s ‘Step into the Light’ webinar on 21 January.

IONICON PTR-MS System Monitors GMP Biotech Processes
Tuesday, January 21, 2014
PTR-MS analyze VOCs in real-time and in very low concentrations.

Quattroflow™ 1200SU-M Series Single-Use Quaternary Diaphragm Pumps
Monday, January 20, 2014
Now available with injected molded plastic pump chambers.

Wyatt Technology to Present Seminar and Poster at WCBP 2014
Monday, January 13, 2014
The Company will present on innovative light scattering techniques in Washington, DC, January 28 – 30.

Malvern Instruments Publishes New White Paper to Coincide with PepTalk 2014
Wednesday, January 08, 2014
Company publishes new white paper on ‘Developing a bioformulation stability profile’.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 407
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv